Psych Central - Clinical Trials for Schizophrenia

Clinical Trials for Schizophrenia

Found 931 studies with search of:

schizophrenia

Hide studies that are not seeking new volunteers.

1	Active, not recruiting	Supervised Treatment of Schizophrenia, a Randomized Controlled Trial.
		Conditions:	Schizophrenia; Schizoaffective Disorders
		Intervention:	Behavioral: Supervised Treatment of Schizophrenia by a family member

2	Recruiting	Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia
		Condition:	Schizophrenia
		Interventions:	Behavioral: Culturally informed therapy for schizophrenia (CIT-S); Behavioral: Psychoeducation treatment as usual

3	Completed	Single Nucleotide Polymorphism (SNP) in Schizophrenia and Schizophrenia Spectrum Disorders: a Population Association Analysis With Hong Kong Chinese
		Condition:	Schizophrenia
		Intervention:	Procedure: Extraction of 10ml blood sample for extraction of genomic DNA using DNA purification kits

4	Recruiting	Clinical Trial of Dipyridamole in Schizophrenia
		Conditions:	Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
		Intervention:	Drug: Dipyridamole

5	Completed	Effects of Atomoxetine on Cognitive Function in Schizophrenia
		Conditions:	Schizophrenia; Cognition; Smoking
		Intervention:	Drug: Atomoxetine (Strattera™)

6	Recruiting	Genetic Study of Schizophrenia
		Conditions:	Psychotic Disorder; Schizoaffective Disorder; Schizophrenia
		Intervention:

7	Recruiting	Cardio Risk of Acute Schizophrenia Olanzapine Duke
		Conditions:	Schizophrenia; Schizoaffective Disorder
		Interventions:	Drug: Olanzapine; Drug: Metformin; Drug: Simvastatin

8	Recruiting	Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia
		Conditions:	Schizophrenia; Schizoaffective Disorder
		Intervention:	Drug: D-serine

9	Completed	A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions
		Conditions:	Schizophrenia; Latent Schizophrenia
		Intervention:

10	Recruiting	Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia
		Conditions:	Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
		Intervention:	Behavioral: Family-Directed Cognitive Adaptation Program

11	Recruiting	The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia
		Condition:	Schizophrenia
		Intervention:	Drug: Champix

12	Completed	A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia
		Condition:	Schizophrenia
		Intervention:	Drug: paliperidone palmitate

13	Completed	CATIE- Schizophrenia Trial
		Condition:	Schizophrenia
		Interventions:	Drug: perphenazine; Drug: olanzapine; Drug: quetiapine; Drug: risperidone; Drug: ziprasidone; Drug: clozapine; Drug: fluphenazine decanoate

14	Active, not recruiting	Schizophrenia and Genetic Counseling
		Condition:	Schizophrenia
		Intervention:

15	Recruiting	MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia.
		Conditions:	Paranoid Schizophrenia; Schizophrenia
		Interventions:	Drug: MK0557; Drug: Comparator: Placebo (unspecified)

16	Terminated	Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
		Condition:	Schizophrenia
		Intervention:	Drug: Org 24448 (Ampakine)

17	Recruiting	Treatment Study for Cognitive Deficits in Schizophrenia
		Condition:	Schizophrenia
		Intervention:	Drug: MK-0777

18	Recruiting	Evaluation of Efficacy and Safety of Long-Acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
		Conditions:	Schizophrenia, Catatonic; Schizophrenia, Disorganized; Schizophrenia, Paranoid; Schizophrenia; Psychotic Disorders
		Intervention:	Drug: Long-acting Risperidone microspheres injection

19	Recruiting	A Multicenter Study of NAP (AL-108) in Schizophrenia
		Condition:	Schizophrenia
		Intervention:	Drug: AL-108

20	Recruiting	Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia
		Condition:	Schizophrenia
		Interventions:	Behavioral: Cognitive remediation; Behavioral: Health behavior training; Drug: Risperidone, administered orally; Drug: Risperidone, administered via injection; Behavioral: Individual Placement and Support

21	Active, not recruiting	The Effects of Nicotine on Cognition in Schizophrenia
		Condition:	Schizophrenia
		Intervention:	Drug: transdermal nicotine patch

22	Completed	Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia
		Condition:	Schizophrenia
		Interventions:	Drug: asenapine; Drug: olanzapine

23	Completed	Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia
		Condition:	Schizophrenia
		Intervention:	Drug: Atomoxetine

24	Recruiting	Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
		Condition:	Schizophrenia
		Interventions:	Behavioral: Group Skills Training and Psychoeducation; Behavioral: Individual Case Management; Drug: Oral Risperidone; Drug: Risperidone in Long-Acting Injectable Form (Consta)

25	Recruiting	High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms
		Condition:	Schizophrenia
		Intervention:	Drug: Geodon

26	Not yet recruiting	Oxygen Therapy in Schizophrenia
		Condition:	Chronic Schizophrenia
		Intervention:	Drug: oxygen

27	Recruiting	Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia
		Conditions:	Schizophrenias; Psychoses; Psychotic Disorders; Schizophrenic Disorders
		Intervention:	Drug: Sarcosine (N-methylglycine)

28	Active, not recruiting	Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia
		Condition:	Schizophrenia
		Interventions:	Drug: Asenapine; Drug: Olanzapine

29	Active, not recruiting	Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia
		Condition:	Schizophrenia, Paranoid
		Intervention:	Drug: valproate

30	Recruiting	Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia
		Condition:	Schizophrenia
		Interventions:	Dietary Supplement: Folic acid with B12; Drug: Placebo

31	Active, not recruiting	Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?
		Condition:	Schizophrenia
		Intervention:	Drug: clonidine

32	Completed	Schizophrenia Study In Adults
		Condition:	Schizophrenia
		Interventions:	Drug: talnetant; Drug: risperidone

33	Completed	Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia
		Conditions:	Schizophrenia; Psychoses
		Intervention:	Other: maintained antipsychotic treatment vs. stepwise drug discontinuation

34	Completed	Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia
		Condition:	Schizophrenia
		Intervention:	Drug: SPECT Imaging of Nicotinic Acetylcholine Receptors in Brain

35	Not yet recruiting	A Canadian Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia
		Condition:	Schizophrenia
		Intervention:	Drug: Quetiapine Fumarate Extended- Release

36	Recruiting	Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes
		Conditions:	Schizophrenia; Schizoaffective Disorder; Bipolar Disorder
		Intervention:	Drug: ziprasidone vs. aripiprazole

37	Completed	Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients
		Condition:	Schizophrenia
		Intervention:	Drug: memantine HCl

38	Completed	Pregnenolone in the Management of Schizophrenia Patients
		Condition:	Schizophrenia
		Intervention:	Drug: Pregnenolone

39	Not yet recruiting	Direct, Noninvasive Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients
		Conditions:	Schizophrenia; Cardiovascular Disease
		Intervention:

40	Recruiting	Efficacy and Safety of AVE1625 as a co-Treatment With Antipsychotic Therapy in Schizophrenia
		Condition:	Schizophrenia
		Intervention:	Drug: AVE1625

41	Completed	Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia
		Conditions:	Schizophrenia; Psychoses
		Intervention:	Drug: antipsychotics vs. Lorazepam (Drugs)

42	Recruiting	Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)
		Conditions:	Schizophrenia; Schizoaffective Disorder
		Intervention:	Device: Transcranial Magnetic Stimulation (TMS)

43	Active, not recruiting	Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia
		Conditions:	Schizophrenia; Schizoaffective Disorder; Tardive Dyskinesia; Insulin Resistance; Obesity
		Intervention:	Drug: Panax Ginseng

44	Completed	Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder
		Conditions:	Schizophrenia; Schizoaffective Disorder
		Intervention:	Drug: Olanzapine

45	Active, not recruiting	Eye Blink Response in Healthy Volunteers and Adults With Schizophrenia
		Conditions:	Healthy; Schizophrenia
		Intervention:

46	Completed	A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia
		Condition:	Schizophrenia
		Intervention:	Drug: paliperidone palmitate

47	Completed	A Study of the Long-Term Safety and Tolerability and the Long-Term Effectiveness of Extended-Release Oral Paliperidone in Patients Diagnosed With Schizophrenia
		Condition:	Schizophrenia
		Intervention:	Drug: paliperidone ER Oros

48	Completed	Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome
		Conditions:	Schizophrenia; Schizophrenic Disorder
		Intervention:	Behavioral: Community Re-Entry Program: What is Schizophrenia

49	Completed	Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
		Conditions:	Schizophrenias; Psychoses; Psychotic Disorders; Schizophrenic Disorders
		Intervention:	Drug: Sarcosine and D-serine

50	Recruiting	Open-Label Study of Flexible-Dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
		Conditions:	Schizophrenic Disorders; Schizophrenia; Dementia Praecox.; Psychotic Disorders
		Intervention:	Drug: Paliperidone ER

Studies Shown (1-50)

Next (51-100)

RSS Feed for studies received in the last 14 days

Download Options

Back